Oceana Therapeutics wins US FDA approval of fecal incontinence drug
This article was originally published in Scrip
Executive Summary
The US FDA on 27 May approved Oceana Therapeutics injectable gel product Solesta to treat fecal incontinence, or involuntary loss of bowel control, in patients who have failed other therapies, such as diet change, fiber therapy or antimotility medications.